Thieme Chemistry and the Editors of Science of Synthesis announce the Margaret Faul Women in Chemistry Prize 2021.
Proposals must be accompanied by:
The material will be confidentially forwarded to an independent selection committee. Self-nomination is not permitted.
Nomination material should be submitted by e-mail to Dr Marcus White (E-Mail) by December 11, 2020.
Selection Committee Chairs
Dr Margaret Faul
Amgen Inc. | CA, USA
Prof. Dr Alois Fürstner
Max-Planck-Institut für Kohlenforschung | Mülheim, Germany
The second Dr Margaret Faul Women in Chemistry Award Ceremony and Lecture will be held at the European Symposium on Organic Chemistry (ESOC 2021) in Ghent on Tuesday, July 13, 2021.
You can find more details on the Thieme official website.
Margaret Faul is Vice President of Drug Product Technologies at Amgen Inc, in Thousand Oaks, CA. She is responsible to develop the commercial processes for modalities within the Amgen portfolio from preclinical to commercial and has a strong knowledge of GMP, regulatory and compliance issues as they relate to the development of these pharmaceutical products.
Margaret received her B.Sc. and M.Sc degrees from University College Dublin, Ireland. In 1987 she moved to the United States where she received her Ph.D. degree in Synthetic Organic Chemistry from Harvard University with Professor David A. Evans. In 1993 Margaret joined the Chemical Process group at Eli Lilly and Company and in 2003 went to Amgen Inc, in Thousand Oaks, CA where she is currently Vice President of Drug Product Technologies within the Process Development organization.
During her 25-year career Margaret has leveraged her technical experience to support programs across all stages of development from preclinical to commercial focused on the process development and supply of drug substance and drug product for clinical trials and the commercial market. Margaret has experience working with Commercial Manufacturing Organizations worldwide and an ability to work with partners during licensing activities to ensure seamless integration and development of programs with the partner company. Margaret has a strong knowledge of GMP, regulatory and compliance issues as they relate to the development of pharmaceutical products. Margaret has received numerous awards in recognition of her leadership and mentorship including the Earle B. Barnes Award for Leadership in Chemical Research Management from Dow Chemical Company and the American Chemical Society and a HBA Rising Star Award.